Wilkins Investment Counsel Inc. Has $1.08 Million Position in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Share on StockTwits

Wilkins Investment Counsel Inc. cut its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 34.6% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 23,600 shares of the pharmacy operator’s stock after selling 12,500 shares during the quarter. Wilkins Investment Counsel Inc.’s holdings in Walgreens Boots Alliance were worth $1,080,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in WBA. NEXT Financial Group Inc increased its stake in shares of Walgreens Boots Alliance by 43.1% in the fourth quarter. NEXT Financial Group Inc now owns 4,141 shares of the pharmacy operator’s stock valued at $245,000 after buying an additional 1,248 shares in the last quarter. J.W. Cole Advisors Inc. acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at $477,000. Advisor Partners LLC increased its stake in shares of Walgreens Boots Alliance by 10.6% in the fourth quarter. Advisor Partners LLC now owns 16,776 shares of the pharmacy operator’s stock valued at $913,000 after buying an additional 1,604 shares in the last quarter. Sumitomo Life Insurance Co. increased its stake in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Sumitomo Life Insurance Co. now owns 17,924 shares of the pharmacy operator’s stock valued at $1,057,000 after buying an additional 841 shares in the last quarter. Finally, Valeo Financial Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 70.4% in the fourth quarter. Valeo Financial Advisors LLC now owns 5,488 shares of the pharmacy operator’s stock valued at $324,000 after buying an additional 2,268 shares in the last quarter. Institutional investors own 57.19% of the company’s stock.

WBA traded down $0.15 during midday trading on Monday, reaching $39.60. 3,391,244 shares of the company were exchanged, compared to its average volume of 7,348,387. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance Inc has a one year low of $36.65 and a one year high of $64.50. The stock has a market capitalization of $34.74 billion, a P/E ratio of 10.15, a PEG ratio of 1.83 and a beta of 0.55. The stock’s 50-day simple moving average is $42.22 and its 200 day simple moving average is $51.33.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.46 by $0.06. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The firm had revenue of $35.82 billion for the quarter, compared to analysts’ expectations of $35.24 billion. During the same quarter last year, the business earned $1.64 earnings per share. The company’s revenue was up 3.7% compared to the same quarter last year. On average, research analysts anticipate that Walgreens Boots Alliance Inc will post 5.53 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Wednesday, May 20th will be issued a dividend of $0.4575 per share. This represents a $1.83 annualized dividend and a dividend yield of 4.62%. The ex-dividend date is Tuesday, May 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 30.55%.

WBA has been the subject of a number of research reports. Barclays lowered their price objective on Walgreens Boots Alliance from $60.00 to $50.00 and set an “equal weight” rating for the company in a research report on Friday, April 3rd. ValuEngine lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, March 3rd. UBS Group upgraded Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and lowered their price objective for the stock from $49.00 to $44.00 in a research report on Monday, April 6th. Wells Fargo & Co reiterated a “hold” rating on shares of Walgreens Boots Alliance in a research report on Thursday, April 2nd. Finally, Deutsche Bank upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating and lowered their price objective for the stock from $51.00 to $43.00 in a research report on Friday, April 3rd. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. The stock has a consensus rating of “Hold” and an average target price of $51.21.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: How is the S&P 500 index different from the DJIA?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.